Is there any precedent for meeting with the FDA to discuss phase 3 tests to potentially make them more efficient? What are we expecting in this meeting?
Neuren Media and Analyst Coverage, page-1351
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.68 |
Change
0.030(0.22%) |
Mkt cap ! $1.746B | |||
| Open | High | Low | Value | Volume |
| $13.70 | $13.76 | $13.63 | $244.1K | 17.85K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 217 | $13.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.69 | 118 | 7 |
View Market Depth
| Last trade - 10.58am 17/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |